Last reviewed · How we verify
E6005 0.2%
At a glance
| Generic name | E6005 0.2% |
|---|---|
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis (PHASE1, PHASE2)
- A Study of E6005 in Japanese Patients With Atopic Dermatitis (PHASE1, PHASE2)
- A Phase 2 Study of E6005 in Patients With Atopic Dermatitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |